ConductScience.org, home

Paper40856423

The GNL3L-MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression.

Yang A and 2 others. Cancer Med, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. The GNL3L-MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression. Papers, record 40856423. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40856423

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The GNL3L-MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression.
PubMed
Journal
Cancer Med
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-25
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang AAijie
2Song HHaiyun
3Cheng YYufenghttps://orcid.org/0009-0001-6010-6822

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Proto-Oncogene Proteins c-mdm2Major topic
Esophageal NeoplasmsMajor topic
Esophageal Squamous Cell CarcinomaMajor topic
Humans
Animals
Mice
Disease Progression
Cell Proliferation
Cell Line, Tumor
Apoptosis
Female
Male
Cell Movement
Mice, Nude
Gene Expression Regulation, Neoplastic
Tumor Suppressor Protein p53
Middle Aged
Cyclin-Dependent Kinase Inhibitor p21

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132287078A Scoring Method for Immunohistochemical Staining on Ki67.Appl Immunohistochem Mol Morphol2021https://conductscience.org/library/papers/32287078PubMed
226550276MDM2 T309G polymorphism and esophageal cancer risk: a meta-analysis.Int J Clin Exp Med2015https://conductscience.org/library/papers/26550276PubMed
334900524Advances and challenges in the treatment of esophageal cancer.Acta Pharm Sin B2021https://conductscience.org/library/papers/34900524PubMed
434050758GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA.Nucleic Acids Res2021https://conductscience.org/library/papers/34050758PubMed
532913098The GTEx Consortium atlas of genetic regulatory effects across human tissues.Science2020https://conductscience.org/library/papers/32913098PubMed
635392233PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy.Front Oncol2022https://conductscience.org/library/papers/35392233PubMed
716251348The homologous putative GTPases Grn1p from fission yeast and the human GNL3L are required for growth and play a role in processing of nucleolar pre-rRNA.Mol Biol Cell2006https://conductscience.org/library/papers/16251348PubMed
827764577Leucine Zipper Down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling during cell proliferation.Cell Cycle2016https://conductscience.org/library/papers/27764577PubMed
937393256Genomic and transcriptional characterization of early esophageal squamous cell carcinoma.BMC Med Genomics2023https://conductscience.org/library/papers/37393256PubMed
1021132010GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest.Oncogene2011https://conductscience.org/library/papers/21132010PubMed
1124610951Nucleostemin and GNL3L exercise distinct functions in genome protection and ribosome synthesis, respectively.J Cell Sci2014https://conductscience.org/library/papers/24610951PubMed
1234733320Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.Front Genet2021https://conductscience.org/library/papers/34733320PubMed
1333932560Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.Biochim Biophys Acta Rev Cancer2021https://conductscience.org/library/papers/33932560PubMed
1435361964Cell cycle regulation: p53-p21-RB signaling.Cell Death Differ2022https://conductscience.org/library/papers/35361964PubMed
1526796597MDM2 gene amplification in esophageal carcinoma.Oncol Rep2016https://conductscience.org/library/papers/26796597PubMed
1638617454MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma.World J Gastroenterol2024https://conductscience.org/library/papers/38617454PubMed
1716978205Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment II.Histopathology2006https://conductscience.org/library/papers/16978205PubMed
1817034816A novel lysine-rich domain and GTP binding motifs regulate the nucleolar retention of human guanine nucleotide binding protein, GNL3L.J Mol Biol2006https://conductscience.org/library/papers/17034816PubMed
1919487455GNL3L stabilizes the TRF1 complex and promotes mitotic transition.J Cell Biol2009https://conductscience.org/library/papers/19487455PubMed
2038572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed

See all 40 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42591837Garcinoic acid promotes ferroptosis-associated growth inhibition in esophageal squamous cell carcinoma through an MDM2-associated mechanism.Transl Cancer Res2026https://conductscience.org/library/papers/42591837PubMed
42444932GNL3L-LMNB1 signaling axis promotes lung squamous cell carcinoma growth and ferroptosis resistance via NF-κB activation.J Thorac Dis2026https://conductscience.org/library/papers/42444932PubMed
40856423The GNL3L-MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression.Cancer Med2025https://conductscience.org/library/papers/40856423PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GNL3L54552PubTator's text mininghttps://conductscience.org/library/genes/54552NCBI Gene
H3P16644914PubTator's text mininghttps://conductscience.org/library/genes/644914NCBI Gene
MDM24193PubTator's text mininghttps://conductscience.org/library/genes/4193NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40856423

GET https://conductscience.org/api/papers/v1/40856423/references?page=2